. . . . . . . . . . . . . "p(RGD:Ngf) -> p(RGD:Casp1)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "NGF treatment of differentiated oligodendrocytes resulted in processing of 45 kDa Caspase-1 pro-form to its intermediate forms and to final active product p10. This indicates that Caspase-1 was preferentially activated during NGF-induced oligodendrocyte apoptosis" . . "Selventa" . . . . "2014-07-03T14:29:46.449+02:00"^^ . . .